C82.8A
Other types of follicular lymphoma, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that primarily affects the lymphatic system, which is an integral part of the immune system. When diagnosed, it often presents as slow-growing or indolent. The specific ICD-10 code C82.8A refers to cases of follicular lymphoma that are not currently active but are in remission, indicating that symptoms have subsided following treatment. This state can persist for years, and ongoing monitoring is essential to manage the condition effectively. Understanding the nature of follicular lymphoma in remission helps patients grasp their health status and the importance of follow-up care.
Causes & Symptoms
Clinical Causes: Genetic mutations in lymphocytes leading to abnormal growth Age-related changes in immune system functioning Environmental factors such as exposure to certain chemicals or radiation Family history of lymphoid cancers Immunodeficiency conditions that impair immune surveillance
Key Symptoms: Swollen and painless lymph nodes in areas such as the neck, armpits, or groin Unexplained weight loss Fever or night sweats Fatigue or weakness Frequent infections due to compromised immune response
Diagnostic & Treatment
Diagnosis Path: The diagnosis of follicular lymphoma typically involves a combination of procedures. These may include physical examinations focused on lymph node swellings, blood tests to assess overall health, and imaging studies such as CT scans to determine the extent of lymph node involvement. A definitive diagnosis is usually made through a biopsy of affected lymph node tissue, examined microscopically for characteristic cancer cell patterns. Once diagnosed, staging helps determine the disease's spread, guiding treatment and prognosis.
Treatment Protocols: Management of follicular lymphoma varies based on disease stage and patient health. Initially, treatments may include watchful waiting in cases where the disease is slow-growing and asymptomatic. When active treatment is necessary, options include chemotherapy, immunotherapy with monoclonal antibodies, radiation therapy, or targeted therapies. Achieving remission involves reducing cancer signs and symptoms, often confirmed through follow-up biopsies and imaging. During remission, ongoing monitoring is crucial to detect any signs of recurrence early. Supportive care may involve managing side effects and maintaining overall health.
Clinical Advice & FAQs
Billing Guidance
Is C82.8A a billable ICD-10 code?
Yes, C82.8A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.8A?
Clinical documentation must specify the nature of Other types of follicular lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference